Skip to main content
SpringerLink
Log in

Combination chemotherapy (COMP protocol) and radiotherapy of anaplastic supratentorial gliomas

  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

Postoperative survival time and recurrence-free intervals in 116 consecutive patients with supratentorial grade III and IV gliomas (glioblastomas, gliosarcomas, anaplastic astrocytomas, and ependymomas) were compared in unselected groups receiving different forms of treatment. Postoperative high-voltage radiotherapy (31 patients, dosage 4,000–6,000 rads) and combined chemotherapy consisting of CCNU, vincristine, amethopterine, and procarbazine in 15-day circles (COMP protocol) (12 patients) showed the same median survival time of 10.6 months and comparable recurrence-free intervals of 6.8 and 7.0 months, respectively. These results were significantly different from a control group (39 patients) receiving best postoperative supportive (conventional) care (median survival 5.4 months, free interval 3.7 months). Combination of postoperative radiotherapy with simultaneous polychemotherapy (COMP protocol), evaluated in 18 patients, did not significantly change the recurrence-free interval (median 7.0 months), but increased the median survival time to 12.9 months, which was significantly superior to the two other treatment groups.

The toxic side effects of COMP therapy were moderate and essentially haematological. In general, simultaneous radiation and chemical treatment was well tolerated after major tumour resection. These preliminary results of postoperative combination of radiation and polychemotherapy for anaplastic supratentorial gliomas appear encouraging, but further trials for optimization of combined therapeutic strategies are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andersen, A. P., Postoperative irradiation of glioblastomas. Results in a randomized study. Acta Radiol. Oncol.17 (1978), 475–484.

    Google Scholar 

  2. Blaylock, R. L., Kempe, L. G., Review and new proposals for immunotherapy of brain tumors. Neurochir. (Stuttg.)19 (1976), 10–21.

    Google Scholar 

  3. Brisman, R., Housepian, E. M., Chang, C., Duffy, P., Balis, E., Adjuvant nitrosurea therapy for glioblastoma. Arch. Neurol. (Chic.)33 (1976), 745–750.

    Google Scholar 

  4. Buge, A., Poisson, M., Pouillart, P., La chimiothérapie séquentielle des glioblastomes. Etude de 176 cas. Rev. Neurol.134 (1978), 369–378.

    PubMed  Google Scholar 

  5. Crafts, D. C., Wilson, C. B., Basis and results of chemotherapeutic treatment of gliomas. Bull. Cancer64 (1977), 101–114.

    PubMed  Google Scholar 

  6. Delarvalho, S., Kaufman, A., Pineda, A., Adjuvant chemoimmunotherapy in CNS tumors. In: Adjuvant therapy of cancer, pp. 495–504 (Salmon, S. E., Jones, S. E., eds.). Amsterdam: North Holland. 1978.

    Google Scholar 

  7. EORTC Brain Tumor Group: Effect of CCNU on survival rate of objective remission and duration of free interval in patients in the malignant brain glioma-first evaluation. Europ. J. Cancer12 (1976), 41–45.

    Google Scholar 

  8. Goldsmith, M. A., Carter, S. K., Glioblastoma multiforme—a review of therapy. Cancer Treatm. Rev.1 (1974), 155–165.

    Google Scholar 

  9. Grunert, V., Jellinger, K., Sunder-Plassmann, M., Wöber, G., Glioblastoma multiforme: a preliminary follow-up study. In: Modern aspects of neurosurgery, Vol.3, pp. 108–115. Amsterdam: E. Medica, ICS 287, 1973.

    Google Scholar 

  10. Haferkamp, G., Gutjahr, P., Reulen, H. J., Derzeitige Therapie maligner Tumoren des ZNS. Akt. Neurol.5 (1978), 105–113.

    Google Scholar 

  11. Heiss, W. D., Chemotherapy of malignant glioma: Comparison of the effect of polychemo- and CCNU-therapy. Acta Neurochir. (Wien)42 (1978), 109–115.

    Google Scholar 

  12. Heiss, W. D., Turnheim, M., Mamoli, B., Combination chemotherapy of malignant glioma. Effect of postoperative treatment with CCNU, vincristine, amethopterine and procarbazine. Europ. J. Cancer14 (1978), 1191–1202.

    Google Scholar 

  13. Hildebrand, J., Brihaye, J., Chemotherapy of brain tumours. In: Advances and technical standards in neurosurgery, Vol. 5, pp. 52–91 (Krayenbühl, H., ed.). Wien-New York: Springer. 1978.

    Google Scholar 

  14. Hochberg, F. H., Linggood, R. M., Baker, W. H., Wolfson, L., Kornblith, P. L., Combined modality therapy of glioblastoma multiforme: a 4-year retrospective experience (abstr.) Neurology (Minneap.)27 (1977), 366.

    Google Scholar 

  15. Hoshino, T., Wilson, C. B., Rosenblum, M. L., Barker, M., Chemotherapy implications of growth fraction and cell cycle time in glioblastomas. J. Neurosurg.43 (1975), 127–135.

    PubMed  Google Scholar 

  16. Jellinger, K., Glioblastoma multiforme: morphology and biology. Acta Neuro-chir. (Wien)42 (1978), 5–32.

    Google Scholar 

  17. Kahr, E., Megavoltage therapy of glioblastoma multiforme. Acta Neurochir. (Wien)42 (1978), 79–87.

    Google Scholar 

  18. Kernohan, J. W., Sayre, G. P., Tumors of the central nervous system. Atlas of tumor pathology; Sect. X, Fasc. 35, Washington, D. C.: Armed Forces Institute of Pathology. 1952.

    Google Scholar 

  19. Laramore, G. E., Griffin, T. W., Gerdes, A. J., Parker, R. G., Fast neutron and mixed (neutron/photon) beam teletherapy for grades III and IV astrocytomas. Cancer42 (1978), 96–103.

    PubMed  Google Scholar 

  20. Levin, V. A., Crafts, D. G., Norman, D. M., Hoffer, P. B., Spire, J. P., Wilson, C. B., Criteria for evaluating malignant brain tumor patients undergoing chemotherapy. J. Neurosurg.47 (1977), 329–336.

    PubMed  Google Scholar 

  21. Müller, P. J., Tator, C. H., The effect of amphotericin B on the survival of brain-tumor-bearing mice treated with CCNU. J. Neurosurg.49 (1978), 579–588.

    PubMed  Google Scholar 

  22. Müller, W., Schröder, R., Zur Diagnostik der Gliome. Neurochir. (Stuttgart)11 (1968), 30–36.

    Google Scholar 

  23. Ommaya, A. K., Immunotherapy of gliomas: a review. Adv. Neurology15, 337–359. New York: Raven Press. 1976.

    Google Scholar 

  24. Paoletti, P., Robustelli della Cuna, G., Knerich, R., Strada, M. R., Multidisciplinary treatment for central nervous system tumours with nitrosurea compounds. Acta Neurochir. (Wien)41 (1978), 287–299.

    Google Scholar 

  25. Petrovici, J. N., Ilsen, H. W., Chemotherapy of brain tumors. Advances in neurosurgery, Vol.5, 292–296. Berlin-Heidelberg-New York: Springer. 1978.

    Google Scholar 

  26. Ragan, T. H., Bisel, H. F., Childs, D. S., Jr., Layton, D. D., Rhoton, A. L., Taylor, W. F., Controlled study of CCNU and radiation/therapy in malignant astrocytoma. J. Neurosurg.44 (1976), 186–190.

    PubMed  Google Scholar 

  27. Ringertz, N., Grading of gliomas. Acta path. microbiol. scand.27 (1950), 51–64.

    PubMed  Google Scholar 

  28. Rosenblum, M. L., Knebel, K. D., Vaquez, D. A., Wilson, C. B., Brain-tumor therapy. Quantitative analysis using a model system. J. Neurosurg.46 (1976), 145–154.

    Google Scholar 

  29. Rubin, P., Carter, S. K., Combination radiation therapy and chemotherapy: a logical basis. Cancer J. Clin.26 (1976), 274–292.

    Google Scholar 

  30. Russell, D. S., Rubinstein, K. J., Pathology of tumours of the nervous system, 4th ed. London: E. Arnold. 1976.

    Google Scholar 

  31. Seiler, R. W., Greiner, R. H., Zimmermann, A., Markwalder, H., Radiotherapy, combined with probarbazine, bleomycin, and CCNU in the treatment of highgrade supratentorial astrocytomas. J. Neurosurg.48 (1978), 861–865.

    PubMed  Google Scholar 

  32. Schiffer, D., Giordana, M. T., Pezzotta, S., Paoletti, P., Chemotherapeutic effects of some alkylating derivatives of nitrosourea on the development of tumors transplacentally induced in rats by E.N.U.: Acta Neuropath. (Berl.)34 (1976), 21–31.

    Google Scholar 

  33. Shapiro, W. R., Young, D. F., Treatment of malignant glioma. A controlled study of chemotherapy and irradiation. Arch. Neurol. (Chic.)33 (1976), 494–500.

    Google Scholar 

  34. Walker, M. D., Weiss, H. D., Chemotherapy in the treatment of malignant brain tumors. Adv. Neurology, Vol.13, 149–191. New York: Raven Press. 1975.

    Google Scholar 

  35. Walker, M. D., Alexander, E., Hunt, W. F.,et al., Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J. Neurosurg.49 (1978), 333–343.

    PubMed  Google Scholar 

  36. Walker, M. D., Strike, T. A., An evaluation of Methyl-CCNU, BCNU and radiotherapy in the treatment of malignant glioma (abstr.) Proc. Amer. Assoc. Cancer Res.17 (1976), 163.

    Google Scholar 

  37. Weir, B., Band, P., Urtasun, R., Blain, G., McLean, D., Wilson, F., Mielke, B., Grace, M., Radiotherapy and CCNU in the treatment of supratentorial astrocytomas. J. Neurosurg.45 (1976), 129–134.

    PubMed  Google Scholar 

  38. Wilcoxon, F., A generalized Wilcoxon test for comparing arbitrarily single-censored samples. Biometrica52 (1965), 203–215.

    Google Scholar 

  39. Wilson, C. B., Chemotherapy of brain tumors. In: Advances in neurology, Vol.15, 361–368 (Thompson, R. A., Green, J. R., eds.). Berlin-Heidelberg-New York: Springer. 1976.

    Google Scholar 

  40. Wilson, C. B., Gutin, P., Boldrey, E. B., Crafts, D., Levin, V. A., Enot, K. J., Single-agent chemotherapy of brain tumors. A five-year review. Arch. Neurol. (Chic.)33 (1976), 739–744.

    Google Scholar 

  41. Wilson, C. B., Yorke, C., jr., Levin, V. A., Intracranial malignant growth, primary and metastatic. In: Current problems in cancer (Hickey, R. C., ed.). Year Book Med. Publ. 1977.

Download references

Author information

Author notes

  1. K. Jellinger

    Present address: Ludwig Boltzmann Institute of Clinical Neurobiology and Department of Neurology, Lainz-Hospital, Vienna, Austria

Authors and Affiliations

  1. Ludwig Boltzmann Institute of Clinical Neurobiology and Department of Neurology, Lainz-Hospital, Vienna, Austria

    P. Kothbauer, D. Volc, R. Vollmer & R. Weiß

Authors
  1. K. Jellinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Kothbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Volc
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Vollmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Weiß
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jellinger, K., Kothbauer, P., Volc, D. et al. Combination chemotherapy (COMP protocol) and radiotherapy of anaplastic supratentorial gliomas. Acta neurochir 51, 1–13 (1979). https://doi.org/10.1007/BF01401790

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01401790

Keywords

Search

Navigation